[1]
N. M. Seredyuk and O. Z. Skakun, “FEATURES OF THE CLINICAL COURSE OF COVID-19-ASSOCIATED PNEUMONIA IN PATIENTS RECEIVING STATINS”, pulse, no. 18 (66), pp. 53–68, Dec. 2022.